Cargando…

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon

BACKGROUND: Coinfection with hepatitis B virus (HBV) or hepatitis C virus (HCV) in HIV-infected patients receiving a commonly used nevirapine-based antiretroviral therapy is a major concern for African clinicians owing to its high prevalence, the infrequent testing and treatment of viral hepatitis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbougua, Jules B Tchatchueng, Laurent, Christian, Kouanfack, Charles, Bourgeois, Anke, Ciaffi, Laura, Calmy, Alexandra, Gwet, Henri, Koulla-Shiro, Sinata, Ducos, Jacques, Mpoudi-Ngolé, Eitel, Molinari, Nicolas, Delaporte, Eric
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841671/ https://www.ncbi.nlm.nih.gov/pubmed/20193053 http://dx.doi.org/10.1186/1471-2458-10-105

Ejemplares similares

Antiretroviral Drug Resistance and Routine Therapy, Cameroon
por: Laurent, Christian, et al.
Publicado: (2006)

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013)

HIV and Hepatitis C Virus Coinfection, Cameroon
por: Laurent, Christian, et al.
Publicado: (2007)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
por: Liégeois, Florian, et al.
Publicado: (2020)

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
por: Ciaffi, Laura, et al.
Publicado: (2015)

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
por: Temfack, Elvis, et al.
Publicado: (2018)

A randomized blinded controlled trial of mobile phone reminders on the follow-up medical care of HIV-exposed and HIV-infected children in Cameroon: study protocol (MORE CARE)
por: Bigna, Jean Joel R, et al.
Publicado: (2013)

Commercial Logging and HIV Epidemic, Rural Equatorial Africa
por: Laurent, Christian, et al.
Publicado: (2004)

Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the “Stratall ANRS 12110 / ESTHER” trial
por: Sandie, Arsene Brunelle, et al.
Publicado: (2022)

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon
por: Ndawinz, Jacques DA, et al.
Publicado: (2015)

Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets
por: Boullé, Charlotte, et al.
Publicado: (2016)

Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
por: Aghokeng, Avelin F., et al.
Publicado: (2009)

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa
por: Boyer, S., et al.
Publicado: (2019)

Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon
por: Kouam, Marc K, et al.
Publicado: (2013)

Hot-spots of HIV infection in Cameroon: a spatial analysis based on Demographic and Health Surveys data
por: Sandie, Arsène Brunelle, et al.
Publicado: (2022)

Association of Nevirapine Levels with Rash or Hepatotoxicity Among HIV-Infected Thai Women
por: Ratanasuwan, Winai, et al.
Publicado: (2012)

Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study
por: Namme Luma, Henry, et al.
Publicado: (2012)

Antioxidant modulation of nevirapine induced hepatotoxicity in rats
por: Awodele, Olufunsho, et al.
Publicado: (2015)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
por: Tongo, Marcel, et al.
Publicado: (2013)

Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Barriers to the implementation of mobile phone reminders in pediatric HIV care: a pre-trial analysis of the Cameroonian MORE CARE study
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Noninvasive western lowland gorilla's health monitoring: A decade of simian immunodeficiency virus surveillance in southern Cameroon
por: Villabona‐Arenas, Christian Julian, et al.
Publicado: (2018)

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study
por: Kabore, Firmin Nongodo, et al.
Publicado: (2017)

Nevirapine Plasma Concentrations Are Associated with Virologic Response and Hepatotoxicity in Chinese Patients with HIV Infection
por: Wang, Jia, et al.
Publicado: (2011)

Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City
por: Nzalie, Rolf Nyah-tuku, et al.
Publicado: (2016)

Dynamics of Antibodies to Ebolaviruses in an Eidolon helvum Bat Colony in Cameroon
por: Djomsi, Dowbiss Meta, et al.
Publicado: (2022)

Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study
por: Luma, Henry Namme, et al.
Publicado: (2013)

Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2015)

Factors associated with non-adherence to antiretroviral therapy among HIV-infected adolescents aged 15-19 years: a snapshot from the Mother and Child Center in Yaounde, Cameroon
por: Lantche, Martial Wandji, et al.
Publicado: (2021)

Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country
por: Tongo, Marcel, et al.
Publicado: (2015)

Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon
por: Kamgno, Joseph, et al.
Publicado: (2020)

Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Douala, Cameroon: A Cross Sectional Study
por: Luma, Henry Namme, et al.
Publicado: (2013)

Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013)
por: Bigna, Jean Joel R., et al.
Publicado: (2015)

Exposure to Nonhuman Primates in Rural Cameroon
por: Wolfe, Nathan D., et al.
Publicado: (2004)

APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa
por: Kabore, Nongodo Firmin, et al.
Publicado: (2021)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in Cameroon
por: Torimiro, Judith N., et al.
Publicado: (2013)

Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon
por: Tagnouokam-Ngoupo, Paul Alain, et al.
Publicado: (2021)

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)
por: Bousmah, Marwân-al-Qays, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eqir1h6aodt4o79oclmjgf2i8a